Syra Health Corp
SYRA· OTC
SYRASyra Health Corp
Filed Aug 12, 2025 · 10-Q · 43 days after period end · 0001641172-25-023235
| Metric | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|
| Revenue | $1.95M | $1.97M | $979.25K |
| Net Income | -$63.60K | -$1.39M | -$802.80K |
| EPS Diluted | -$0.01 | -$0.21 | -$0.18 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Syra Health Corp · CIK 1922335 · Engraved from SEC EDGAR
ended Jun 30, 2025 · filed Aug 12, 2025 · 43 d after period end
